Quotient Sciences Increases spray drying capabilities in the U.S.
6 / 49 articles displayed
News
Quotient Sciences, the innovative provider of early phase drug development services, is pleased to announce that Chief Compliance Officer, Simon Lee, has been elected as Secretary of the European CRO Federation (“EUCROF”).
Awards
Quotient Sciences, the unique and innovative provider of drug development services, today announced it has received a British Private Equity & Venture Capital Association (BVCA) Management Team Award.
Growth
Quotient Sciences, the Translational Pharmaceutics® company, a leading provider of early stage and specialist drug development services, today announced the expansion of its Data Sciences function with relocation to a larger office, staying in Edinburgh.
Association
Quotient are delighted to host a gathering of inhaled medicine experts at the next European Pharmaceutical Aerosol Group (EPAG) meeting.
Showcase
Quotient Sciences is holding a series of formulation development and drug delivery seminars this June and July. The seminars will take place at major life science hubs in the UK and USA, and will address the most pressing challenges currently faced by pharmaceutical and biotechnology companies in early drug development.
Showcase
Quotient Sciences will present two poster publications at the forthcoming 11th International ISSX Meeting 2016 in Busan, South Korea. The poster publications describe recent advancements in the design of integrated clinical programs to generate pivotal pharmacokinetic and metabolism data addressing key development and regulatory requirements.
